Ratto-Kim Silvia, Yoon In-Kyu, Paris Robert M, Excler Jean-Louis, Kim Jerome H, O'Connell Robert J
International Vaccine Institute, Seoul, South Korea.
GSK Vaccines, Rockville, MD, United States.
Front Immunol. 2018 Jun 21;9:1397. doi: 10.3389/fimmu.2018.01397. eCollection 2018.
The US military has been a leading proponent of vaccine development since its founding. General George Washington ordered the entire American army to be variolated against smallpox after recognizing the serious threat that it posed to military operations. He did this on the recommendation from Dr. John Morgan, the physician-in-chief of the American army, who wrote a treatise on variolation in 1776. Although cases of smallpox still occurred, they were far fewer than expected, and it is believed that the vaccination program contributed to victory in the War of Independence. Effective military force requires personnel who are healthy and combat ready for worldwide deployment. Given the geography of US military operations, military personnel should also be protected against diseases that are endemic in potential areas of conflict. For this reason, and unknown to many, the US military has strongly supported vaccine research and development. Four categories of communicable infectious diseases threaten military personnel: (1) diseases that spread easily in densely populated areas (respiratory and dysenteric diseases); (2) vector-borne diseases (disease carried by mosquitoes and other insects); (3) sexually transmitted diseases (hepatitis, HIV, and gonorrhea); and (4) diseases associated with biological warfare. For each category, the US military has supported research that has provided the basis for many of the vaccines available today. Although preventive measures and the development of drugs have provided some relief from the burden of malaria, dengue, and HIV, the US military continues to fund research and development of prophylactic vaccines that will contribute to force health protection and global health. In the past few years, newly recognized infections with Zika, severe acute respiratory syndrome, Middle East respiratory syndrome viruses have pushed the US military to fund research and fast track clinical trials to quickly and effectively develop vaccines for emerging diseases. With US military personnel present in every region of the globe, one of the most cost-effective ways to maintain military effectiveness is to develop vaccines against prioritized threats to military members' health.
自建国以来,美国军方一直是疫苗研发的主要支持者。乔治·华盛顿将军在认识到天花对军事行动构成的严重威胁后,下令对整个美国军队进行天花接种。他是根据美国军队的首席医师约翰·摩根博士的建议这样做的,摩根博士在1776年撰写了一篇关于接种的论文。尽管天花病例仍有发生,但比预期的要少得多,人们认为疫苗接种计划对独立战争的胜利起到了促进作用。有效的军事力量需要健康且随时准备好进行全球部署的人员。考虑到美国军事行动的地理范围,军事人员还应防范潜在冲突地区流行的疾病。出于这个原因,而且很多人并不知晓,美国军方一直大力支持疫苗研发。四类传染病威胁着军事人员:(1)在人口密集地区容易传播的疾病(呼吸道和痢疾疾病);(2)媒介传播疾病(由蚊子和其他昆虫传播的疾病);(3)性传播疾病(肝炎、艾滋病毒和淋病);以及(4)与生物战相关的疾病。对于每一类疾病,美国军方都支持了相关研究,这些研究为当今许多可用疫苗奠定了基础。尽管预防措施和药物研发在一定程度上减轻了疟疾、登革热和艾滋病毒带来的负担,但美国军方仍继续资助预防性疫苗的研发,这将有助于部队健康保护和全球健康。在过去几年里,新发现的寨卡病毒、严重急性呼吸综合征、中东呼吸综合征病毒感染促使美国军方资助研究并加快临床试验,以便快速有效地研发针对新出现疾病的疫苗。由于美国军事人员遍布全球各个地区,维持军事效能最具成本效益 的方法之一就是研发针对军事人员健康面临的优先威胁的疫苗。